Actively Recruiting
Patch-free Occlusion Therapy
Led by Retina Foundation of the Southwest · Updated on 2026-01-07
68
Participants Needed
1
Research Sites
218 weeks
Total Duration
On this page
Sponsors
R
Retina Foundation of the Southwest
Lead Sponsor
N
National Eye Institute (NEI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of the study is to determine whether a patch-free occlusion therapy leads to better visual outcomes in young children with amblyopia than standard-of-care occlusion therapy with an adhesive patch and whether this is associated with better adherence to the treatment.
CONDITIONS
Official Title
Patch-free Occlusion Therapy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 3-12 years
- male and female
- strabismic, anisometropic, or combined mechanism amblyopia (visual acuity: 0.3-0.8 logMAR)
- interocular visual acuity difference ≥0.3 logMAR
- wearing glasses (if needed) for a minimum of 8 weeks with no change in visual acuity at 2 visits ≥4 weeks apart
- child's ophthalmologist and family willing to forgo standard patching treatment during the study
You will not qualify if you...
- Prematurity ≥8 wk
- coexisting ocular or systemic disease
- developmental delay
- myopia > -3.00D
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Retina Foundation
Dallas, Texas, United States, 75231
Actively Recruiting
Research Team
E
Eileen E Birch, PhD
CONTACT
R
Reed M Jost, MS
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here